SMT201700231T1 - Inibitori del proteasoma per il trattamento di cancro - Google Patents

Inibitori del proteasoma per il trattamento di cancro

Info

Publication number: SMT201700231T1
Authority: SM; San Marino
Prior art keywords: treating cancer; proteasome inhibitors; proteasome; inhibitors; cancer
Prior art date: 2009-10-01

Application number

SM20170231T

Other languages

English (en)

Inventor

De Velde Helgi Van

Coster Roland De

Martine Bayssas

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-10-01

Filing date

2010-10-01

Publication date

2017-07-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43629456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201700231(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-10-01 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2017-07-18 Publication of SMT201700231T1 publication Critical patent/SMT201700231T1/it

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SM20170231T 2009-10-01 2010-10-01 Inibitori del proteasoma per il trattamento di cancro SMT201700231T1 (it)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US24771409P	2009-10-01	2009-10-01
PCT/EP2010/005994 WO2011038924A2 (en)	2009-10-01	2010-10-01	Treatment of disease with proteasome inhibitors
EP10807320.6A EP2519231B1 (en)	2009-10-01	2010-10-01	Proteasome inhibitors for treating cancer

Publications (1)

Publication Number	Publication Date
SMT201700231T1 true SMT201700231T1 (it)	2017-07-18

Family

ID=43629456

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM20170231T SMT201700231T1 (it)	2009-10-01	2010-10-01	Inibitori del proteasoma per il trattamento di cancro

Country Status (18)

Country	Link
US (1)	US20110189204A1 (it)
EP (1)	EP2519231B1 (it)
JP (1)	JP2013506626A (it)
AU (2)	AU2010300259A1 (it)
CA (1)	CA2776327A1 (it)
CY (1)	CY1118925T1 (it)
DK (1)	DK2519231T3 (it)
ES (1)	ES2624644T3 (it)
HR (1)	HRP20170702T1 (it)
HU (1)	HUE032571T2 (it)
LT (1)	LT2519231T (it)
ME (1)	ME02725B (it)
PL (1)	PL2519231T3 (it)
PT (1)	PT2519231T (it)
RS (1)	RS55931B1 (it)
SI (1)	SI2519231T1 (it)
SM (1)	SMT201700231T1 (it)
WO (1)	WO2011038924A2 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2776043B1 (en) *	2011-11-11	2018-02-21	Millennium Pharmaceuticals, Inc.	Biomarkers of response to proteasome inhibitors
CA2966288A1 (en)	2014-10-30	2016-05-06	Big Dna Ltd	Combination therapy
EP3365018A1 (en) *	2015-10-20	2018-08-29	The Cleveland Clinic Foundation	Stimulation of 11beta -hsd2 expression to improve hormonal therapy of steroid-dependent disease
US11947330B2 (en) *	2019-03-06	2024-04-02	The Boeing Company	Tool orientation systems and methods

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4499802A (en) *	1982-09-29	1985-02-19	Container Graphics Corporation	Rotary cutting die with scrap ejection
US4537773A (en)	1983-12-05	1985-08-27	E. I. Du Pont De Nemours And Company	α-Aminoboronic acid derivatives
US4499082A (en)	1983-12-05	1985-02-12	E. I. Du Pont De Nemours And Company	α-Aminoboronic acid peptides
US5081110A (en) *	1986-03-27	1992-01-14	Sloan-Kettering Institute For Cancer Research	Method of killing sarcoma cells using fludarabine phosphate and ionizing radiation
US6083903A (en) *	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
WO2000047230A1 (fr) *	1999-02-10	2000-08-17	The Kitasato Institute	Potentialisateurs d'agent anticancereux
DE60239384D1 (de)	2001-01-25	2011-04-21	Us Of America Represented By The Secretary Dept Of Health And Human Services	Formulierungen von borsäure-verbindungen
WO2006077425A1 (en)	2005-01-21	2006-07-27	Astex Therapeutics Limited	Combinations of pyrazole kinase inhibitors and further antitumor agents
CA2594477C (en)	2005-01-21	2016-07-12	Astex Therapeutics Limited	Pharmaceutical compounds
US20060193844A1 (en) *	2005-02-28	2006-08-31	Proteolix, Inc.	Methods for enzyme inhibition
EP1876893B1 (en)	2005-04-15	2012-04-11	Geron Corporation	Cancer treatment by combined inhibition of proteasome and telomerase activities
TW200836749A (en) *	2007-01-09	2008-09-16	Vioquest Pharmaceuticals Inc	Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
KR101544498B1 (ko) *	2007-08-24	2015-08-17	스티칭 허트 네덜란드 칸커 인스티튜트	종양성 질환의 치료를 위한 조성물

2010
- 2010-10-01 SM SM20170231T patent/SMT201700231T1/it unknown
- 2010-10-01 HR HRP20170702TT patent/HRP20170702T1/hr unknown
- 2010-10-01 DK DK10807320.6T patent/DK2519231T3/en active
- 2010-10-01 PL PL10807320T patent/PL2519231T3/pl unknown
- 2010-10-01 WO PCT/EP2010/005994 patent/WO2011038924A2/en not_active Ceased
- 2010-10-01 RS RS20170474A patent/RS55931B1/sr unknown
- 2010-10-01 EP EP10807320.6A patent/EP2519231B1/en not_active Revoked
- 2010-10-01 ES ES10807320.6T patent/ES2624644T3/es active Active
- 2010-10-01 JP JP2012531285A patent/JP2013506626A/ja active Pending
- 2010-10-01 ME MEP-2017-106A patent/ME02725B/me unknown
- 2010-10-01 PT PT108073206T patent/PT2519231T/pt unknown
- 2010-10-01 CA CA2776327A patent/CA2776327A1/en not_active Abandoned
- 2010-10-01 SI SI201031448A patent/SI2519231T1/sl unknown
- 2010-10-01 HU HUE10807320A patent/HUE032571T2/en unknown
- 2010-10-01 US US12/896,289 patent/US20110189204A1/en not_active Abandoned
- 2010-10-01 AU AU2010300259A patent/AU2010300259A1/en not_active Abandoned
- 2010-10-01 LT LTEP10807320.6T patent/LT2519231T/lt unknown
2016
- 2016-12-22 AU AU2016277700A patent/AU2016277700A1/en not_active Abandoned
2017
- 2017-06-01 CY CY20171100580T patent/CY1118925T1/el unknown

Also Published As

Publication number	Publication date
AU2010300259A1 (en)	2012-04-26
SI2519231T1 (sl)	2017-07-31
LT2519231T (lt)	2017-05-10
CY1118925T1 (el)	2018-01-10
EP2519231A2 (en)	2012-11-07
WO2011038924A9 (en)	2011-07-14
HUE032571T2 (en)	2017-09-28
US20110189204A1 (en)	2011-08-04
WO2011038924A2 (en)	2011-04-07
PL2519231T3 (pl)	2017-09-29
JP2013506626A (ja)	2013-02-28
DK2519231T3 (en)	2017-06-26
PT2519231T (pt)	2017-05-25
WO2011038924A3 (en)	2011-05-26
CA2776327A1 (en)	2011-04-07
ME02725B (me)	2017-10-20
AU2016277700A1 (en)	2017-02-02
RS55931B1 (sr)	2017-09-29
HRP20170702T1 (hr)	2017-07-14
ES2624644T3 (es)	2017-07-17
EP2519231B1 (en)	2017-03-15

Publication	Publication Date	Title
PT2440545T (pt)	2019-07-19	Compostos úteis para tratar cancro
HUE060305T2 (hu)	2023-02-28	FAP-aktivált proteaszóma inhibitorok a szolid tumorok kezelésére
IL218987A0 (en)	2012-06-28	Methods and compositions for treating cancer
ZA201205004B (en)	2013-09-25	Methods for treating pancreatic cancer
IL215767A0 (en)	2012-01-31	Methods of treatment for solid tumors
ZA201200263B (en)	2012-09-26	Compounds and methods for treating influenza
EP2424516A4 (en)	2014-04-02	PENTAMIDINE COMBINATIONS FOR THE TREATMENT OF CANCER
IL196208A0 (en)	2009-09-22	Methods for cancer treatment using tak1 inhibitors
IL213398A0 (en)	2011-07-31	Compounds for treating cancer
IL228644A0 (en)	2013-12-31	Cancer treatment methods
ZA201108118B (en)	2013-04-24	Treatment regimin utilizing neratinib for breast cancer
PL2493565T3 (pl)	2017-09-29	Metoda radioterapii
IL218230A0 (en)	2012-04-30	Method of treating cancer
PT2519231T (pt)	2017-05-25	Inibidores do proteassoma para tratamento do cancro
EP2560648A4 (en)	2013-10-02	METHOD OF TREATING PANCREATIC CANCER
IL213919A0 (en)	2011-07-31	Methods to treat cancer
ZA201202379B (en)	2013-06-26	Antagonists of dsgs2 for treatment of cancer
PT2509599E (pt)	2014-10-15	Processo para o tratamento de cancro pancreático
IL215199A0 (en)	2011-12-29	Thia-triaza-cyclopentazulenes as pi3-kinases inhibitors for the treatment of cancer
ZA201201894B (en)	2012-11-28	Pharmaceutical combination for treating tumor
GB0914322D0 (en)	2009-09-30	Compounds for treating cancer
GB201019034D0 (en)	2010-12-22	Treatment for tumors
GB0903650D0 (en)	2009-04-15	Glyoalase inhibitors
GB0902661D0 (en)	2009-04-01	Inhibitors
GB0901497D0 (en)	2009-03-11	Compound for therapy